Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.

Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio S.

Lancet HIV. 2020 Feb 5. pii: S2352-3018(19)30400-X. doi: 10.1016/S2352-3018(19)30400-X. [Epub ahead of print]

2.

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.

Makurumidze R, Mutasa-Apollo T, Decroo T, Choto RC, Takarinda KC, Dzangare J, Lynen L, Van Damme W, Hakim J, Magure T, Mugurungi O, Rusakaniko S.

PLoS One. 2020 Jan 7;15(1):e0222309. doi: 10.1371/journal.pone.0222309. eCollection 2020.

3.

Viral load testing among women on 'option B+' in Mazowe, Zimbabwe: How well are we doing?

Nyakura J, Shewade HD, Ade S, Mushavi A, Mukungunugwa SH, Chimwaza A, Owiti P, Senkoro M, Mugurungi O.

PLoS One. 2019 Dec 3;14(12):e0225476. doi: 10.1371/journal.pone.0225476. eCollection 2019.

4.

Strengthening the scale-up and uptake of effective interventions for sex workers for population impact in Zimbabwe.

Cowan FM, Chabata ST, Musemburi S, Fearon E, Davey C, Ndori-Mharadze T, Bansi-Matharu L, Cambiano V, Steen R, Busza J, Yekeye R, Mugurungi O, Hargreaves JR, Phillips AN.

J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25320. doi: 10.1002/jia2.25320.

5.

Retesting for verification of HIV diagnosis before antiretroviral therapy initiation in Harare, Zimbabwe: Is there a gap between policy and practice?

Dupwa B, Kumar AMV, Tripathy JP, Mugurungi O, Takarinda KC, Dzangare J, Bara H, Mukeredzi I.

Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):610-616. doi: 10.1093/trstmh/trz047.

PMID:
31225614
6.

Economic cost analysis of door-to-door community-based distribution of HIV self-test kits in Malawi, Zambia and Zimbabwe.

Mangenah C, Mwenge L, Sande L, Ahmed N, d'Elbée M, Chiwawa P, Chigwenah T, Kanema S, Mutseta MN, Nalubamba M, Chilongosi R, Indravudh P, Sibanda EL, Neuman M, Ncube G, Ong JJ, Mugurungi O, Hatzold K, Johnson CC, Ayles H, Corbett EL, Cowan FM, Maheswaran H, Terris-Prestholt F.

J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25255. doi: 10.1002/jia2.25255.

7.

Identifying high or low risk of mother to child transmission of HIV: How Harare City, Zimbabwe is doing?

Komtenza B, Satyanarayana S, Takarinda KC, Mukungunugwa SH, Mugurungi O, Chonzi P, Sithole N, Bvochora T, Mushavi A.

PLoS One. 2019 Mar 13;14(3):e0212848. doi: 10.1371/journal.pone.0212848. eCollection 2019.

8.

Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.

Mavhu W, Hatzold K, Madidi N, Maponga B, Dhlamini R, Munjoma M, Xaba S, Ncube G, Mugurungi O, Cowan FM.

PLoS One. 2019 Mar 11;14(3):e0213399. doi: 10.1371/journal.pone.0213399. eCollection 2019.

9.

Antiretroviral adverse drug reactions pharmacovigilance in Harare City, Zimbabwe, 2017.

Mugauri H, Tshimanga M, Mugurungi O, Juru T, Gombe N, Shambira G.

PLoS One. 2018 Dec 19;13(12):e0200459. doi: 10.1371/journal.pone.0200459. eCollection 2018.

10.

Towards UNAIDS Fast-Track goals: targeting priority geographic areas for HIV prevention and care in Zimbabwe.

Cuadros DF, Li J, Mukandavire Z, Musuka GN, Branscum AJ, Sartorius B, Mugurungi O, Tanser F.

AIDS. 2019 Feb 1;33(2):305-314. doi: 10.1097/QAD.0000000000002052.

PMID:
30557161
11.

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study.

Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A.

Lancet HIV. 2019 Feb;6(2):e116-e127. doi: 10.1016/S2352-3018(18)30317-5. Epub 2018 Nov 29.

12.

Economy, migrant labour and sex work: interplay of HIV epidemic drivers in Zimbabwe over three decades.

Steen R, Hontelez JAC, Mugurungi O, Mpofu A, Matthijsse SM, de Vlas SJ, Dallabetta GA, Cowan FM.

AIDS. 2019 Jan 27;33(1):123-131. doi: 10.1097/QAD.0000000000002066.

13.

90-90-90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe - 2017 to 2020.

Bansi-Matharu L, Cambiano V, Apollo T, Yekeye R, Dirawo J, Musemburi S, Davey C, Napierala S, Fearon E, Mpofu A, Mugurungi O, Hargreaves JR, Cowan FM, Phillips AN.

J Int AIDS Soc. 2018 Nov;21(11):e25205. doi: 10.1002/jia2.25205.

14.

A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe.

Tlhajoane M, Masoka T, Mpandaguta E, Rhead R, Church K, Wringe A, Kadzura N, Arinaminpathy N, Nyamukapa C, Schur N, Mugurungi O, Skovdal M, Eaton JW, Gregson S.

Health Res Policy Syst. 2018 Sep 21;16(1):92. doi: 10.1186/s12961-018-0358-1.

15.

Early Infant Diagnosis Sample Management in Mashonaland West Province, Zimbabwe, 2017.

Mugauri H, Mugurungi O, Chadambuka A, Juru T, Gombe NT, Shambira G, Tshimanga M.

AIDS Res Treat. 2018 Jul 26;2018:4234256. doi: 10.1155/2018/4234256. eCollection 2018.

16.

Engagement in HIV Care Among Young Female Sex Workers in Zimbabwe.

Napierala S, Chabata ST, Fearon E, Davey C, Hargreaves J, Busza J, Mushati P, Mtetwa S, Chiyaka T, Mugurungi O, Hanisch D, Hatzold K, Phillips A, Cowan FM.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):358-366. doi: 10.1097/QAI.0000000000001815.

17.

How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe?

Takarinda KC, Choto R, Sandy C, Apollo T, Duri C, Dube F, Mpofu A, Timire C, Mugurungi O, Makaza V, Tapera R, Harries AD.

Trans R Soc Trop Med Hyg. 2018 Oct 1;112(10):450-457. doi: 10.1093/trstmh/try073.

18.

Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trial.

Cowan FM, Davey C, Fearon E, Mushati P, Dirawo J, Chabata S, Cambiano V, Napierala S, Hanisch D, Wong-Gruenwald R, Masuka N, Mabugo T, Hatzold K, Mugurungi O, Busza J, Phillips A, Hargreaves JR.

Lancet HIV. 2018 Aug;5(8):e417-e426. doi: 10.1016/S2352-3018(18)30111-5. Epub 2018 Jul 18.

19.

Pediatric HIV Treatment Gaps in 7 East and Southern African Countries: Examination of Modeled, Survey, and Routine Program Data.

Saito S, Chung H, Mahy M, Radin AK, Jonnalagadda S, Hakim A, Awor AC, Mwila A, Gonese E, Wadonda-Kabondo N, Rwehumbiza P, Ao T, Kim EJ, Frederix K, Nuwagaba-Birbomboha H, Musuka G, Mugurungi O, Mushii J, Mnisi Z, Munthali G, Jahn A, Kirungi WL, Sivile S, Abrams EJ.

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S134-S141. doi: 10.1097/QAI.0000000000001739.

PMID:
29994836
20.

HIV infection in patients with sexually transmitted infections in Zimbabwe - Results from the Zimbabwe STI etiology study.

Kilmarx PH, Gonese E, Lewis DA, Chirenje ZM, Barr BAT, Latif AS, Gwanzura L, Handsfield HH, Machiha A, Mugurungi O, Rietmeijer CA.

PLoS One. 2018 Jun 11;13(6):e0198683. doi: 10.1371/journal.pone.0198683. eCollection 2018.

21.

HIV Population Surveys - Bringing Precision to the Global Response.

Justman JE, Mugurungi O, El-Sadr WM.

N Engl J Med. 2018 May 17;378(20):1859-1861. doi: 10.1056/NEJMp1801934. No abstract available.

22.

Sexual behavior experiences and characteristics of male-female partnerships among HIV positive adolescent girls and young women: Qualitative findings from Zimbabwe.

Mavhu W, Rowley E, Thior I, Kruse-Levy N, Mugurungi O, Ncube G, Leclerc-Madlala S.

PLoS One. 2018 Mar 22;13(3):e0194732. doi: 10.1371/journal.pone.0194732. eCollection 2018.

23.

The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study.

Chirenje ZM, Dhibi N, Handsfield HH, Gonese E, Tippett Barr B, Gwanzura L, Latif AS, Maseko DV, Kularatne RS, Tshimanga M, Kilmarx PH, Machiha A, Mugurungi O, Rietmeijer CA.

Sex Transm Dis. 2018 Jun;45(6):422-428. doi: 10.1097/OLQ.0000000000000771.

24.

Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.

Dinh TH, Mushavi A, Shiraishi RW, Tippett Barr B, Balachandra S, Shambira G, Nyakura J, Zinyowera S, Tshimanga M, Mugurungi O, Kilmarx PH.

Clin Infect Dis. 2018 Feb 1;66(4):576-585. doi: 10.1093/cid/cix820.

PMID:
29401270
25.

The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial.

Fatti G, Ngorima-Mabhena N, Chirowa F, Chirwa B, Takarinda K, Tafuma TA, Mahachi N, Chikodzore R, Nyadundu S, Ajayi CA, Mutasa-Apollo T, Mugurungi O, Mothibi E, Hoffman RM, Grimwood A.

Trials. 2018 Jan 29;19(1):79. doi: 10.1186/s13063-018-2469-y.

26.

Status of HIV Epidemic Control Among Adolescent Girls and Young Women Aged 15-24 Years - Seven African Countries, 2015-2017.

Brown K, Williams DB, Kinchen S, Saito S, Radin E, Patel H, Low A, Delgado S, Mugurungi O, Musuka G, Tippett Barr BA, Nwankwo-Igomu EA, Ruangtragool L, Hakim AJ, Kalua T, Nyirenda R, Chipungu G, Auld A, Kim E, Payne D, Wadonda-Kabondo N, West C, Brennan E, Deutsch B, Worku A, Jonnalagadda S, Mulenga LB, Dzekedzeke K, Barradas DT, Cai H, Gupta S, Kamocha S, Riggs MA, Sachathep K, Kirungi W, Musinguzi J, Opio A, Biraro S, Bancroft E, Galbraith J, Kiyingi H, Farahani M, Hladik W, Nyangoma E, Ginindza C, Masangane Z, Mhlanga F, Mnisi Z, Munyaradzi P, Zwane A, Burke S, Kayigamba FB, Nuwagaba-Biribonwoha H, Sahabo R, Ao TT, Draghi C, Ryan C, Philip NM, Mosha F, Mulokozi A, Ntigiti P, Ramadhani AA, Somi GR, Makafu C, Mugisha V, Zelothe J, Lavilla K, Lowrance DW, Mdodo R, Gummerson E, Stupp P, Thin K, Frederix K, Davia S, Schwitters AM, McCracken SD, Duong YT, Hoos D, Parekh B, Justman JE, Voetsch AC.

MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):29-32. doi: 10.15585/mmwr.mm6701a6.

27.

The Etiology of Genital Ulcer Disease and Coinfections With Chlamydia trachomatis and Neisseria gonorrhoeae in Zimbabwe: Results From the Zimbabwe STI Etiology Study.

Mungati M, Machiha A, Mugurungi O, Tshimanga M, Kilmarx PH, Nyakura J, Shambira G, Kupara V, Lewis DA, Gonese E, Tippett Barr BA, Handsfield HH, Rietmeijer CA.

Sex Transm Dis. 2018 Jan;45(1):61-68. doi: 10.1097/OLQ.0000000000000694.

28.

The Etiology of Male Urethral Discharge in Zimbabwe: Results from the Zimbabwe STI Etiology Study.

Rietmeijer CA, Mungati M, Machiha A, Mugurungi O, Kupara V, Rodgers L, Kilmarx PH, Roloff AH, Gonese E, Tippett-Barr BA, Shambira G, Lewis DA, Handsfield HH, Tshimanga M.

Sex Transm Dis. 2018 Jan;45(1):56-60. doi: 10.1097/OLQ.0000000000000696.

PMID:
29240635
29.

Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.

Tshimanga M, Makunike-Chikwinya B, Mangwiro T, Tapiwa Gundidza P, Chatikobo P, Murenje V, Herman-Roloff A, Kilmarx PH, Holec M, Gwinji G, Mugurungi O, Murwira M, Xaba S, Barnhart S, Feldacker C.

PLoS One. 2017 Dec 8;12(12):e0189146. doi: 10.1371/journal.pone.0189146. eCollection 2017.

30.

Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.

Saito S, Duong YT, Metz M, Lee K, Patel H, Sleeman K, Manjengwa J, Ogollah FM, Kasongo W, Mitchell R, Mugurungi O, Chimbwandira F, Moyo C, Maliwa V, Mtengo H, Nkumbula T, Ndongmo CB, Vere NS, Chipungu G, Parekh BS, Justman J, Voetsch AC.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25004.

31.

Documenting and explaining the HIV decline in east Zimbabwe: the Manicaland General Population Cohort.

Gregson S, Mugurungi O, Eaton J, Takaruza A, Rhead R, Maswera R, Mutsvangwa J, Mayini J, Skovdal M, Schaefer R, Hallett T, Sherr L, Munyati S, Mason P, Campbell C, Garnett GP, Nyamukapa CA.

BMJ Open. 2017 Oct 6;7(10):e015898. doi: 10.1136/bmjopen-2017-015898.

32.

A case study for a psychographic-behavioral segmentation approach for targeted demand generation in voluntary medical male circumcision.

Sgaier SK, Eletskaya M, Engl E, Mugurungi O, Tambatamba B, Ncube G, Xaba S, Nanga A, Gogolina S, Odawo P, Gumede-Moyo S, Kretschmer S.

Elife. 2017 Sep 13;6. pii: e25923. doi: 10.7554/eLife.25923.

33.

Attitudes and decision-making about early-infant versus early-adolescent male circumcision: Demand-side insights for sustainable HIV prevention strategies in Zambia and Zimbabwe.

Sgaier SK, Sharma S, Eletskaya M, Prasad R, Mugurungi O, Tambatamba B, Ncube G, Xaba S, Nanga A, Gumede-Moyo S, Kretschmer S.

PLoS One. 2017 Jul 27;12(7):e0181411. doi: 10.1371/journal.pone.0181411. eCollection 2017.

34.

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

Auld AF, Shiraishi RW, Oboho I, Ross C, Bateganya M, Pelletier V, Dee J, Francois K, Duval N, Antoine M, Delcher C, Desforges G, Griswold M, Domercant JW, Joseph N, Deyde V, Desir Y, Van Onacker JD, Robin E, Chun H, Zulu I, Pathmanathan I, Dokubo EK, Lloyd S, Pati R, Kaplan J, Raizes E, Spira T, Mitruka K, Couto A, Gudo ES, Mbofana F, Briggs M, Alfredo C, Xavier C, Vergara A, Hamunime N, Agolory S, Mutandi G, Shoopala NN, Sawadogo S, Baughman AL, Bashorun A, Dalhatu I, Swaminathan M, Onotu D, Odafe S, Abiri OO, Debem HH, Tomlinson H, Okello V, Preko P, Ao T, Ryan C, Bicego G, Ehrenkranz P, Kamiru H, Nuwagaba-Biribonwoha H, Kwesigabo G, Ramadhani AA, Ng'wangu K, Swai P, Mfaume M, Gongo R, Carpenter D, Mastro TD, Hamilton C, Denison J, Wabwire-Mangen F, Koole O, Torpey K, Williams SG, Colebunders R, Kalamya JN, Namale A, Adler MR, Mugisa B, Gupta S, Tsui S, van Praag E, Nguyen DB, Lyss S, Le Y, Abdul-Quader AS, Do NT, Mulenga M, Hachizovu S, Mugurungi O, Barr BAT, Gonese E, Mutasa-Apollo T, Balachandra S, Behel S, Bingham T, Mackellar D, Lowrance D, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):558-563. doi: 10.15585/mmwr.mm6621a3.

35.

Good news for sex workers in Zimbabwe: how a court order improved safety in the absence of decriminalization.

Busza J, Mtetwa S, Fearon E, Hofisi D, Mundawarara T, Yekeye R, Magure T, Mugurungi O, Cowan F.

J Int AIDS Soc. 2017 May 15;20(1):21860. doi: 10.7448/IAS.20.1.21860. No abstract available.

36.

Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from Zimbabwe.

Schaefer R, Gregson S, Eaton JW, Mugurungi O, Rhead R, Takaruza A, Maswera R, Nyamukapa C.

AIDS. 2017 Jun 19;31(10):1461-1470. doi: 10.1097/QAD.0000000000001506.

37.

Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013.

Takarinda KC, Sandy C, Masuka N, Hazangwe P, Choto RC, Mutasa-Apollo T, Nkomo B, Sibanda E, Mugurungi O, Harries AD, Siziba N.

Tuberc Res Treat. 2017;2017:6232071. doi: 10.1155/2017/6232071. Epub 2017 Mar 2.

38.

Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?

Wilson KC, Mhangara M, Dzangare J, Eaton JW, Hallett TB, Mugurungi O, Gregson S.

AIDS. 2017 Apr;31 Suppl 1:S95-S102. doi: 10.1097/QAD.0000000000001337.

39.

Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.

Silhol R, Gregson S, Nyamukapa C, Mhangara M, Dzangare J, Gonese E, Eaton JW, Case KK, Mahy M, Stover J, Mugurungi O.

AIDS. 2017 Apr;31 Suppl 1:S41-S50. doi: 10.1097/QAD.0000000000001418.

40.

Unpacking early infant male circumcision decision-making using qualitative findings from Zimbabwe.

Mavhu W, Hatzold K, Ncube G, Fernando S, Mangenah C, Chatora K, Dhlamini R, Mugurungi O, Ticklay I, Cowan FM.

BMC Int Health Hum Rights. 2017 Jan 9;17(1):2. doi: 10.1186/s12914-016-0111-1.

41.

Correction: Modeling Impact and Cost-Effectiveness of Increased Efforts to Attract Voluntary Medical Male Circumcision Clients Ages 20-29 in Zimbabwe.

Kripke K, Hatzold K, Mugurungi O, Ncube G, Xaba S, Gold E, Ahanda KS, Kruse-Levy N, Njeuhmeli E.

PLoS One. 2017 Jan 3;12(1):e0169696. doi: 10.1371/journal.pone.0169696. eCollection 2017.

42.

Correction: Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program.

Njeuhmeli E, Stegman P, Kripke K, Mugurungi O, Ncube G, Xaba S, Hatzold K, Christensen A, Stover J.

PLoS One. 2016 Dec 22;11(12):e0169298. doi: 10.1371/journal.pone.0169298. eCollection 2016.

43.

Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.

Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Sow PS, Ehrenkranz P, Ford D, Mugurungi O, Apollo T, Murungu J, Bangsberg DR, Revill P.

PLoS One. 2016 Dec 15;11(12):e0167654. doi: 10.1371/journal.pone.0167654. eCollection 2016.

44.

The HIV Care Cascade Among Female Sex Workers in Zimbabwe: Results of a Population-Based Survey From the Sisters Antiretroviral Therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial.

Cowan FM, Davey CB, Fearon E, Mushati P, Dirawo J, Cambiano V, Napierala Mavedzenge S, Hanisch D, Wong-Gruenwald R, Chemhuru M, Masuka N, Hatzold K, Mugurungi O, Busza J, Philips AN, Hargreaves JR.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):375-382. doi: 10.1097/QAI.0000000000001255.

45.

Modeling Impact and Cost-Effectiveness of Increased Efforts to Attract Voluntary Medical Male Circumcision Clients Ages 20-29 in Zimbabwe.

Kripke K, Hatzold K, Mugurungi O, Ncube G, Xaba S, Gold E, Ahanda KS, Kruse-Levy N, Njeuhmeli E.

PLoS One. 2016 Oct 26;11(10):e0164144. doi: 10.1371/journal.pone.0164144. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169696.

46.

PrEP implementation research in Africa: what is new?

Cowan FM, Delany-Moretlwe S, Sanders EJ, Mugo NR, Guedou FA, Alary M, Behanzin L, Mugurungi O, Bekker LG.

J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21101. doi: 10.7448/IAS.19.7.21101. eCollection 2016.

47.

Comparative Cost of Early Infant Male Circumcision by Nurse-Midwives and Doctors in Zimbabwe.

Mangenah C, Mavhu W, Hatzold K, Biddle AK, Ncube G, Mugurungi O, Ticklay I, Cowan FM, Thirumurthy H.

Glob Health Sci Pract. 2016 Jul 13;4 Suppl 1:S68-75. doi: 10.9745/GHSP-D-15-00201. Print 2016 Jul.

48.

Perspectives of Parents and Health Care Workers on Early Infant Male Circumcision Conducted Using Devices: Qualitative Findings From Harare, Zimbabwe.

Mavhu W, Hatzold K, Ncube G, Fernando S, Mangenah C, Chatora K, Mugurungi O, Ticklay I, Cowan FM.

Glob Health Sci Pract. 2016 Jul 13;4 Suppl 1:S55-67. doi: 10.9745/GHSP-D-15-00200. Print 2016 Jul.

49.

Safety, Acceptability, and Feasibility of Early Infant Male Circumcision Conducted by Nurse-Midwives Using the AccuCirc Device: Results of a Field Study in Zimbabwe.

Mavhu W, Larke N, Hatzold K, Ncube G, Weiss HA, Mangenah C, Chonzi P, Mugurungi O, Mufuka J, Samkange CA, Gwinji G, Cowan FM, Ticklay I.

Glob Health Sci Pract. 2016 Jul 13;4 Suppl 1:S42-54. doi: 10.9745/GHSP-D-15-00199. Print 2016 Jul.

50.

Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program.

Njeuhmeli E, Stegman P, Kripke K, Mugurungi O, Ncube G, Xaba S, Hatzold K, Christensen A, Stover J.

PLoS One. 2016 Jul 13;11(7):e0159167. doi: 10.1371/journal.pone.0159167. eCollection 2016. Erratum in: PLoS One. 2016 Dec 22;11(12 ):e0169298.

Supplemental Content

Loading ...
Support Center